Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 8/12/2019
SIETES contiene 92850 citas

 
 
 1 a 12 de 12 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Azzouz B, Morel A, Kanagaratman L, Herlem E, Trenque T. Psoriasis after exposure to angiotensin-converting enzyme inhibitors: French pharmacovigilance data and review of the literature. Drug Saf 2019;42:diciembre. [Ref.ID 103209]
2. Cita con resumen
de Boissieu P, Kanagaratnam L, Mahmoudi R, Morel A, Dramé M, Trenque T. Adjudication of osteonecrosis of the jaw in phase III randomized controlled trials of denosumab: a systematic review. Eur J Clin Pharmacol 2017;73:517-23. [Ref.ID 101992]
3. Cita con resumen
Trenque T, Maura C, Herlem E, Vallet C, Sole E, Auriche P, Drame M. Reports of sexual disorders related to serotonin reuptake inhibitors in the French Pharmacovigilance Database: an example of underreporting. Drug Saf 2013;36:515-9. [Ref.ID 95771]
4. Cita con resumen
Trenque T, Herlem E, Auriche P, Dramé M. Serotonin reuptake inhibitors and hyperprolactinaemia: a case/non-case study in the French Pharmacovigilance Database. Drug Saf 2011;34:1161-6. [Ref.ID 91863]
5. Cita con resumen
Marchaisseau V, Molia A, Herlem E, Germain ML, Trenque T. Hallucinations et rêves sous propofol. Therapie 2008;63:141-4. [Ref.ID 83509]
6. Cita con resumen
Kelly WN, Arellano FM, Barnes J, Bergman U, Edwards IR, Fernández AM, Freedman SB, Goldsmith DI, Huang K, Jones JK, McLeay R, Moore N, Stather RH, Trenque T, Troutman WG, van Puijenbroek E, Williams F, Wise RP. Guidelines for submitting adverse event reports for publication. Pharmacoepidemiol Drug Saf 2007;16:581-7. [Ref.ID 80208]
7.
Kelly WN, Arellano FM, Barnes J, Bergman U, Edwards RI, Fernández AM, Freedman SB, Goldsmith DI, Huang KA, Jones JK, McLeay R, Moore N, Stather RH, Trenque T, Troutman WG, van Puijenbroek E, Williams F, Wise RP. Guidelines for submitting adverse event reports for publication. Drug Saf 2007;30:367-73. [Ref.ID 80153]
8. Cita con resumen
Couper M, De Carli G, Dodoo A, Edwards BD, Edwards IR, Giuliani R, Haq AS, Hartigan-Go K, Hugman B, Jones J, Leone R, Lindqvist M, Meyboom R, Moretti U, Sabatini W, Smeraldi C, Trenque T, Valdivieso L, Van Ganse E, van Grootheest K, Velo GP, Venegoni M, Vergnano M. The Erice Manifesto: For global reform of the safety of medicines in patient care. Drug Saf 2007;30:187-90. [Ref.ID 79580]
9.
Petit A, Piednoir D, Germain ML, Trenque T, le réseau français des Centres Régionaux de Pharmacovigilance. Drug-induced hyperprolactinaemia: a case/non-case study in the French Pharmacovigilance Database. Therapie 2003;58:159-63. [Ref.ID 64617]
10.
Frances C, Hoizey G, Millart H, Trenque T. L'utilisation du méthylphénidate (Ritaline®) en France. Therapie 2002;57:189-93. [Ref.ID 62076]
11.
Bisschop D, Germain ML, Munzer M, Trenque T. Thioguanine, pancréatotoxicité?. Therapie 2001;56:67-9. [Ref.ID 55653]
12.
Trenque T, Germain ML. Pravastatin: interaction with oral anticoagulant. BMJ 1996;312:886. [Ref.ID 26341]
Seleccionar todas
 
 1 a 12 de 12